Free Account Opening + AMC Free Demat
Loading...

ANG Lifesciences IPO vs Manav infra projects IPO

Comparision between ANG Lifesciences IPO and Manav infra projects IPO.

IPO Details

ANG Lifesciences IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Manav infra projects IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  ANG Lifesciences IPO Manav infra projects IPO
Logo ANG Lifesciences IPO Logo Manav infra projects IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Oneview Corporate Advisors Pvt. Ltd. Navigant Corporate Advisors Ltd
Registrar Bigshare Services Pvt Ltd Kfin Technologies Limited
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of ANG Lifesciences IPO is up to ₹12.01 Cr whereas the issue size of the Manav infra projects IPO is up to ₹5.51 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Manav infra projects IPO is ₹30.00 per share.

  ANG Lifesciences IPO Manav infra projects IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹80.00 per share ₹30.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 4000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 15,00,800 shares 18,36,000 shares
Issue Size Total (Amount) up to ₹12.01 Cr up to ₹5.51 Cr

IPO Timetable

ANG Lifesciences IPO opens on Aug 29, 2017, while Manav infra projects IPO opens on Sep 04, 2017. The closing date of ANG Lifesciences IPO and Manav infra projects IPO is Aug 31, 2017, and Sep 08, 2017, respectively.

  ANG Lifesciences IPO Manav infra projects IPO
Anchor Bid Date
Issue Open Aug 29, 2017 Sep 04, 2017
Issue Close Aug 31, 2017 Sep 08, 2017
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

ANG Lifesciences IPO P/E ratio is , as compared to Manav infra projects IPO P/E ratio of .

  ANG Lifesciences IPO Manav infra projects IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. million)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 1,302.68 1,383.33 1,110.26 1,509.76 1,525.85
Total Revenue 1,829.67 1,644.35 1,622.54 1,197.17 1,210.25
Profit After Tax 103.16 60.85 0.44 20.53 38.99
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the ANG Lifesciences IPO retail investors (RII) are offered 7,12,000 shares while in Manav infra projects IPO retail investors are offered 7,12,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 0 shares in Manav infra projects IPO.

  ANG Lifesciences IPO Manav infra projects IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 0 shares 0 shares
NII 7,12,000 shares 9,18,000 shares
RII 7,12,000 shares 9,18,000 shares
Employee
Others
Total 14,24,000 shares 18,36,000 shares

Bids Received (Subscription)

ANG Lifesciences IPO subscribed in total, whereas Manav infra projects IPO subscribed .

  ANG Lifesciences IPO Manav infra projects IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)

Comments

Add a public comment...